Shopping Cart 0
Cart Subtotal
AED 0

Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

Myriad Genetics, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Myriad Genetics, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Myriad Genetics, Inc. (Myriad or 'the company') is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company operates a CLIA-certified laboratory facility in Salt Lake City, Utah to perform most of the molecular diagnostic tests; a CLIA-certified laboratory in South San Francisco, California; a single laboratory facility in Munich, Germany to perform the international molecular diagnostic tests; and a CLIA-certified laboratory facility in Austin, Texas. The company has its operations in the US and Europe. Myriad is headquartered in Salt Lake City, Utah.

Scope

- Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments

- Intelligence on Myriad Genetics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Myriad Genetics, Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Myriad Genetics, Inc.: Company Overview 9

Myriad Genetics, Inc.: Overview and Key Facts 9

Myriad Genetics, Inc.: Overview 9

Myriad Genetics, Inc.: Key Facts 9

Myriad Genetics, Inc.: Key Employees 10

Myriad Genetics, Inc.: Key Employee Biographies 12

Myriad Genetics, Inc.: Major Products and Services 18

Myriad Genetics, Inc.: Company History 19

Myriad Genetics, Inc.: Management Statement 23

Myriad Genetics, Inc.: Locations and Subsidiaries 26

Myriad Genetics, Inc.: Key Competitors 27

Myriad Genetics, Inc.: Company Analysis 28

Myriad Genetics, Inc.: Business Description 28

Myriad Genetics, Inc.: SWOT Analysis 29

Myriad Genetics, Inc.: SWOT Overview 29

Myriad Genetics, Inc.: Strengths 29

Myriad Genetics, Inc.: Weaknesses 31

Myriad Genetics, Inc.: Opportunities 31

Myriad Genetics, Inc.: Threats 32

Myriad Genetics, Inc.: Corporate Financial Deals Activity 34

Myriad Genetics, Inc.: Financial Deals Overview 34

Myriad Genetics, Inc.: Targets and Partners 36

Myriad Genetics, Inc.: Top Deals 2014-2018YTD* 37

Myriad Genetics, Inc.: Advisors 38

Myriad Genetics, Inc.: Top Legal Advisors 38

Myriad Genetics, Inc.: Top Financial Advisors 38

Myriad Genetics, Inc.: Mergers and Acquisitions 39

Myriad Genetics, Inc.: Capital Raising 40

Myriad Genetics, Inc.: Partnership 41

Myriad Genetics, Inc.: Recent Developments 42

Myriad Genetics, Inc.: News and Events Summary 42

Myriad Genetics, Inc.: Business Expansion 45

Myriad Genetics, Inc.: Contracts 45

Myriad Genetics, Inc.: Financial Performance 46

Myriad Genetics, Inc.: Market Developments 47

Myriad Genetics, Inc.: Regulatory and Legal Events 47

Myriad Genetics, Inc.: Research & Development 48

Myriad Genetics, Inc.: Strategy and Operations 49

Appendix 50

Contact Us 50

Methodology 50

About MarketLine 51


List Of Figure

List of Figures

Figure 1: Myriad Genetics, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Myriad Genetics, Inc.: M&A Activity by Geography (TTM*)

Figure 3: Myriad Genetics, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Figure 4: Myriad Genetics, Inc.: M&A Average Deal Size-Value (USD m)

Figure 5: Myriad Genetics, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Figure 6: Myriad Genetics, Inc.: M&A Activity by Geography (2014-YTD*2018)

Figure 7: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Figure 8: Myriad Genetics, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Figure 9: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Figure 10: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)


List Of Table

List of Tables

Table 1: Myriad Genetics, Inc.: Key Facts

Table 2: Myriad Genetics, Inc.: Key Employees

Table 3: Myriad Genetics, Inc.: Company History

Table 4: Myriad Genetics, Inc.: Locations and Subsidiaries

Table 5: Myriad Genetics, Inc.: Key Competitors

Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Table 7: Myriad Genetics, Inc.: M&A Activity by Geography (TTM*)

Table 8: Myriad Genetics, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Table 9: Myriad Genetics, Inc.: M&A Average Deal Size-Value (USD m)

Table 10: Myriad Genetics, Inc.: Targets and Partners

Table 11: Myriad Genetics, Inc.: Top Deals 2014-2018YTD*

Table 12: Myriad Genetics, Inc.: Legal Advisor Ranking by Value (USD m)

Table 13: Myriad Genetics, Inc.: Financial Advisor Ranking by Value (USD m)

Table 14: Myriad Genetics, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Table 15: Myriad Genetics, Inc.: M&A Activity by Geography (2014-YTD*2018)

Table 16: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Table 17: Myriad Genetics, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Table 18: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Table 19: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)

Table 20: Myriad Genetics, Inc.: News and Events Summary

Table 21: Myriad Genetics, Inc.: Business Expansion

Table 22: Myriad Genetics, Inc.: Contracts

Table 23: Myriad Genetics, Inc.: Financial Performance

Table 24: Myriad Genetics, Inc.: Market Developments

Table 25: Myriad Genetics, Inc.: Regulatory and Legal Events

Table 26: Myriad Genetics, Inc.: Research & Development

Table 27: Myriad Genetics, Inc.: Strategy and Operations

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Myriad Genetics, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Myriad Genetics, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Myriad Genetics, Inc. (Myriad or 'the company') is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company operates a CLIA-certified laboratory facility in Salt Lake City, Utah to perform most of the molecular diagnostic tests; a CLIA-certified laboratory in South San Francisco, California; a single laboratory facility in Munich, Germany to perform the international molecular diagnostic tests; and a CLIA-certified laboratory facility in Austin, Texas. The company has its operations in the US and Europe. Myriad is headquartered in Salt Lake City, Utah.

Scope

- Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments

- Intelligence on Myriad Genetics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Myriad Genetics, Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Myriad Genetics, Inc.: Company Overview 9

Myriad Genetics, Inc.: Overview and Key Facts 9

Myriad Genetics, Inc.: Overview 9

Myriad Genetics, Inc.: Key Facts 9

Myriad Genetics, Inc.: Key Employees 10

Myriad Genetics, Inc.: Key Employee Biographies 12

Myriad Genetics, Inc.: Major Products and Services 18

Myriad Genetics, Inc.: Company History 19

Myriad Genetics, Inc.: Management Statement 23

Myriad Genetics, Inc.: Locations and Subsidiaries 26

Myriad Genetics, Inc.: Key Competitors 27

Myriad Genetics, Inc.: Company Analysis 28

Myriad Genetics, Inc.: Business Description 28

Myriad Genetics, Inc.: SWOT Analysis 29

Myriad Genetics, Inc.: SWOT Overview 29

Myriad Genetics, Inc.: Strengths 29

Myriad Genetics, Inc.: Weaknesses 31

Myriad Genetics, Inc.: Opportunities 31

Myriad Genetics, Inc.: Threats 32

Myriad Genetics, Inc.: Corporate Financial Deals Activity 34

Myriad Genetics, Inc.: Financial Deals Overview 34

Myriad Genetics, Inc.: Targets and Partners 36

Myriad Genetics, Inc.: Top Deals 2014-2018YTD* 37

Myriad Genetics, Inc.: Advisors 38

Myriad Genetics, Inc.: Top Legal Advisors 38

Myriad Genetics, Inc.: Top Financial Advisors 38

Myriad Genetics, Inc.: Mergers and Acquisitions 39

Myriad Genetics, Inc.: Capital Raising 40

Myriad Genetics, Inc.: Partnership 41

Myriad Genetics, Inc.: Recent Developments 42

Myriad Genetics, Inc.: News and Events Summary 42

Myriad Genetics, Inc.: Business Expansion 45

Myriad Genetics, Inc.: Contracts 45

Myriad Genetics, Inc.: Financial Performance 46

Myriad Genetics, Inc.: Market Developments 47

Myriad Genetics, Inc.: Regulatory and Legal Events 47

Myriad Genetics, Inc.: Research & Development 48

Myriad Genetics, Inc.: Strategy and Operations 49

Appendix 50

Contact Us 50

Methodology 50

About MarketLine 51


List Of Figure

List of Figures

Figure 1: Myriad Genetics, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Figure 2: Myriad Genetics, Inc.: M&A Activity by Geography (TTM*)

Figure 3: Myriad Genetics, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Figure 4: Myriad Genetics, Inc.: M&A Average Deal Size-Value (USD m)

Figure 5: Myriad Genetics, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Figure 6: Myriad Genetics, Inc.: M&A Activity by Geography (2014-YTD*2018)

Figure 7: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Figure 8: Myriad Genetics, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Figure 9: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Figure 10: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)


List Of Table

List of Tables

Table 1: Myriad Genetics, Inc.: Key Facts

Table 2: Myriad Genetics, Inc.: Key Employees

Table 3: Myriad Genetics, Inc.: Company History

Table 4: Myriad Genetics, Inc.: Locations and Subsidiaries

Table 5: Myriad Genetics, Inc.: Key Competitors

Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type-Volume (TTM*)

Table 7: Myriad Genetics, Inc.: M&A Activity by Geography (TTM*)

Table 8: Myriad Genetics, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Table 9: Myriad Genetics, Inc.: M&A Average Deal Size-Value (USD m)

Table 10: Myriad Genetics, Inc.: Targets and Partners

Table 11: Myriad Genetics, Inc.: Top Deals 2014-2018YTD*

Table 12: Myriad Genetics, Inc.: Legal Advisor Ranking by Value (USD m)

Table 13: Myriad Genetics, Inc.: Financial Advisor Ranking by Value (USD m)

Table 14: Myriad Genetics, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Table 15: Myriad Genetics, Inc.: M&A Activity by Geography (2014-YTD*2018)

Table 16: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Table 17: Myriad Genetics, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Table 18: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Table 19: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)

Table 20: Myriad Genetics, Inc.: News and Events Summary

Table 21: Myriad Genetics, Inc.: Business Expansion

Table 22: Myriad Genetics, Inc.: Contracts

Table 23: Myriad Genetics, Inc.: Financial Performance

Table 24: Myriad Genetics, Inc.: Market Developments

Table 25: Myriad Genetics, Inc.: Regulatory and Legal Events

Table 26: Myriad Genetics, Inc.: Research & Development

Table 27: Myriad Genetics, Inc.: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS